Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study
A study published in the Journal of Psychopharmacology has found that feelings of relaxation, rather than mystical experiences are the strongest predictor of positive outcomes in psychedelic-assisted therapy for treatment-resistant psychiatric disorders.
Led by Gregor Hasler at Switzerland’s University of Fribourg, the research challenges the belief that transformative experiences, like ego dissolution, drive the antidepressant effects of psychedelics. As PsyPost reported, the study, which involved 28 patients with conditions like depression and anxiety, as well as 28 healthy participants, was conducted in Switzerland, where psychedelic therapy is legally permitted in medical settings. All participants received either LSD or psilocybin in therapeutic environments designed to promote calm and reflection.
Structure And Approach Of Therapy Sessions
Each session began with two preparatory meetings, where patients discussed goals, potential effects, and coping strategies with their psychiatrist. During the therapy, patients received their dose in a calm, supportive environment with soothing music and optional eye coverings to aid introspection. A psychiatrist was present to guide meditation, if desired, and to ensure comfort.